4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-060756
SVP, Chief Accounting Officer sold 140 shares at $81.14 ($11,360)
- SVP, Chief Accounting Officer gave 819 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
Huizenga Theodore Alan · SVP, Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-13 | Gift : show line 1 in the form | −819 | 14,212 | D | ||
| 2021-10-14 | Sale : show line 2 in the form | −140 | $81.14 | $11,360 | 14,072 | D |
| Open-market sales · 140 sh · avg $81.14 · $11,360 | ||||||
Loading xslF345X03/doc4.xml…